← Browse by Condition
Medical Condition

high risk cardiovascular disease

Total Trials
1
Recruiting Now
1
Trial Phases
Phase 3
NCT07181109 Phase 3
Recruiting

Zilebesiran in Patients With Hypertension Not Adequately Controlled and With Either Established Cardiovascular Disease or High Risk for Cardiovascular Disease

Enrollment
11,000 pts
Location
United States, Austr...
Sponsor
Alnylam Pharmaceuticals
View Trial →